The invention concerne new slimming cosmetic or dermopharmaceutical compositions containing, in a dermatologically acceptable carrier, an association of at least a cholesterol-like molécule, at least a xanthic base, and at least an inhibitor of the de novo synthesis of triglycérides from the glucose in adipocytes.
